US HB1829 | 2021-2022 | 117th Congress

Status

Spectrum: Moderate Partisan Bill (Republican 26-4)
Status: Introduced on March 11 2021 - 25% progression, died in committee
Action: 2021-03-12 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]

Summary

To require the Government Accountability Office to study the role pharmaceutical benefit managers play in the pharmaceutical supply chain and provide Congress with appropriate policy recommendations, and for other purposes.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Pharmacy Benefit Manager Accountability Study Act of 2021

Sponsors


History

DateChamberAction
2021-03-12HouseReferred to the Subcommittee on Health.
2021-03-11HouseReferred to the House Committee on Energy and Commerce.
2021-03-11HouseIntroduced in House

Same As/Similar To

SB298 (Same As) 2021-02-08 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
SB4293 (Related) 2022-12-14 - Placed on Senate Legislative Calendar under General Orders. Calendar No. 647.

Subjects


US Congress State Sources


Bill Comments

feedback